Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Overnight Post-Exercise Recovery After Protein Ingestion Prior to Sleep

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT00991523
First received: October 6, 2009
Last updated: April 19, 2011
Last verified: April 2011
  Purpose

The purpose of this study is to examine the effects of post-exercise protein ingestion prior to sleep on overnight protein kinetics and muscle recovery.


Condition Intervention
Exercise
Resistance Training
Dietary Supplement: protein
Dietary Supplement: placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: Protein Ingestion Prior to Sleep as a Dietary Strategy to Improve Post-exercise, Overnight Recovery.

Resource links provided by NLM:


Further study details as provided by Maastricht University Medical Center:

Primary Outcome Measures:
  • muscle protein synthesis [ Time Frame: 10 hours ] [ Designated as safety issue: No ]

Estimated Enrollment: 24
Study Start Date: October 2009
Study Completion Date: December 2010
Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: sweetened beverage Dietary Supplement: protein
protein
Placebo Comparator: placebo control
placebo
Dietary Supplement: placebo
placebo control

  Eligibility

Ages Eligible for Study:   20 Years to 30 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male
  • Age between 20 and 30 years
  • Healthy, recreationally active
  • BMI <25 kg/m2

Exclusion Criteria:

  • Use of medication
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00991523

Locations
Netherlands
Maastricht MUMC
Maastricht, LI, Netherlands, 6202
MaastrichtUMC
Maastricht, Netherlands
Sponsors and Collaborators
Maastricht University Medical Center
GlaxoSmithKline
Investigators
Principal Investigator: Luc van Loon, PhD Maastricht University Medical Center
  More Information

No publications provided by Maastricht University Medical Center

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Luc van Loon, University Hospital Maastricht
ClinicalTrials.gov Identifier: NCT00991523     History of Changes
Other Study ID Numbers: MEC 09-3-054
Study First Received: October 6, 2009
Last Updated: April 19, 2011
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Maastricht University Medical Center:
resistance
exercise
protein
recovery

ClinicalTrials.gov processed this record on November 25, 2014